Use of Eflornithine (DFMO) in the Treatment of Early Alzheimer's Disease: A Compassionate Use, Single-Case Study

Background: Recent genome-wide association screening (GWAS) studies have linked Alzheimer's disease (AD) neuropathology to gene networks that regulate immune function. Kan et al. recently reported that Arg1 (an anti-inflammatory gene that codes for arginase-1) is expressed in parts of the brain...

Descripción completa

Detalles Bibliográficos
Autores principales: Alber, Jessica, McGarry, Kelly, Noto, Richard B., Snyder, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845715/
https://www.ncbi.nlm.nih.gov/pubmed/29559907
http://dx.doi.org/10.3389/fnagi.2018.00060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845715/
https://www.ncbi.nlm.nih.gov/pubmed/29559907
http://dx.doi.org/10.3389/fnagi.2018.00060

Ejemplares similares